GSK said the EMA accepted its submission to update the label for Bexsero to add a single-dose booster for people aged 10+ who were vaccinated in infancy. The regulatory milestone supports potential product expansion, though no approval timing or financial guidance changes were provided.
GSK said the EMA accepted its submission to update the label for Bexsero to add a single-dose booster for people aged 10+ who were vaccinated in infancy. The regulatory milestone supports potential product expansion, though no approval timing or financial guidance changes were provided.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialOverall Sentiment
mildly positive
Sentiment Score
0.25
Ticker Sentiment
